Merck Settles With States Over Vioxx Marketing

Law360, New York (May 20, 2008, 12:00 AM EDT) -- Merck & Co. has agreed to open up its checkbook again to resolve allegations related to its painkiller Vioxx, this time agreeing to pay $58 million to settle allegations that the company downplayed health risks in consumer advertisements.

The settlement, which was announced Tuesday, was reached with the attorneys general from 29 states and the District of Columbia. The deal also requires Merck to obtain U.S. Federal Drug Administration approval before running television drug advertisements for new pain medications.

“I am pleased to announce this settlement...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.